ACORN BIOVENTURES
Our invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
Similar Organizations
Cherrystone Angel Group
Providence based angel group interested in biopharma, medical device and tech startups in New England.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-30 | X4 Pharmaceuticals | Acorn Bioventures investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
| 2022-03-30 | Neuron23 | Acorn Bioventures investment in Series C - Neuron23 | 100 M USD |
| 2022-01-06 | ONK Therapeutics | Acorn Bioventures investment in Series A - ONK Therapeutics | 21.5 M USD |
| 2021-11-11 | Acrivon Therapeutics | Acorn Bioventures investment in Series B - Acrivon Therapeutics | 100 M USD |
| 2021-09-03 | Renovacor | Acorn Bioventures investment in Post-IPO Equity - Renovacor | 30 M USD |
| 2021-05-24 | Eliem Therapeutics | Acorn Bioventures investment in Series B - Eliem Therapeutics | 60 M USD |
| 2021-03-04 | OnKure Therapeutics | Acorn Bioventures investment in Series B - OnKure Therapeutics | 56.65 M USD |
| 2021-02-08 | Gemini Therapeutics | Acorn Bioventures investment in Post-IPO Equity - Gemini Therapeutics | 95 M USD |
| 2021-01-06 | Aileron Therapeutics | Acorn Bioventures investment in Post-IPO Secondary - Aileron Therapeutics | 35.9 M USD |
| 2020-12-16 | Neuron23 | Acorn Bioventures investment in Series B - Neuron23 | 80 M USD |